% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{Wohlgemuth:145148,
author = {Wohlgemuth, Anne and Michalowsky, Bernhard and Wucherer,
Diana and Eichler, Tilly and Thyrian, Jochen René and
Zwingmann, Ina and Rädke, Anika and Hoffmann, Wolfgang},
title = {{D}rug-{R}elated {P}roblems {I}ncrease {H}ealthcare {C}osts
for {P}eople {L}iving with {D}ementia.},
journal = {Journal of Alzheimer's disease},
volume = {73},
number = {2},
issn = {1387-2877},
address = {Amsterdam},
publisher = {IOS Press},
reportid = {DZNE-2020-00507},
pages = {791-799},
year = {2020},
abstract = {Drug-related problems (DRP) are common in the elderly
population, especially in people living with dementia (PwD).
DRP are associated with adverse outcomes that could result
in increased costs.The objective of the study was to analyze
the association between DRP and healthcare costs in PwD.The
analysis was based on the cross-sectional data of 424 PwD.
Compliance, adverse effects, and drug administration of
prescribed and over-the-counter drugs taken were assessed.
DRP were identified and classified by pharmacists using an
adapted German version of 'PIE-Doc®'. Healthcare
utilization was assessed retrospectively used to calculated
costs from a public payer perspective using standardized
unit costs. The associations between DRP and healthcare
costs were analyzed using multiple linear regression
models.394 PwD $(93\%)$ had at least one DRP. An
inappropriate drug choice was significantly associated with
increased total costs (b = 2,718€; $CI95\%$
1,448-3,988) due to significantly higher costs for
hospitalization (b = 1,936€; 670-3,202) and for
medications (b = 417€; 68-765). Problems with
medication dosage and drug interactions were significantly
associated with higher medication costs (b = 679€;
31-1,328; and b = 630€; 259-1,001, respectively).DRP
could significantly lead to adverse outcomes for PwD and
healthcare payers, reflected by a higher hospitalization and
costs, respectively. Further research is needed to clarify
on interventions and approaches efficiently avoiding DRP and
on the effect on patient-reported and economic outcomes.},
keywords = {Aged / Aged, 80 and over / Cross-Sectional Studies /
Dementia: economics / Drug Interactions / Drug-Related Side
Effects and Adverse Reactions: economics / Drug-Related Side
Effects and Adverse Reactions: epidemiology / Female /
Germany: epidemiology / Health Care Costs: statistics $\&$
numerical data / Humans / Male / Nonprescription Drugs /
Patient Acceptance of Health Care / Patient Compliance /
Pharmacists / Prescription Drugs / Retrospective Studies /
Socioeconomic Factors},
cin = {AG Michalowsky ; AG Michalowsky / AG Grabe / AG Thyrian /
AG Hoffmann},
ddc = {610},
cid = {I:(DE-2719)5000067 / I:(DE-2719)5000001 /
I:(DE-2719)1510800 / I:(DE-2719)1510600},
pnm = {344 - Clinical and Health Care Research (POF3-344)},
pid = {G:(DE-HGF)POF3-344},
typ = {PUB:(DE-HGF)16},
pubmed = {pmid:31884468},
doi = {10.3233/JAD-190819},
url = {https://pub.dzne.de/record/145148},
}